Skip to content

Brief Hospitalization for Schizophrenia: Strategies to Improve Treatment Outcome

Brief Hospitalization for Schizophrenia: Strategies to Improve Treatment Outcome

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00018837
Enrollment
Unknown
Registered
2001-07-05
Start date
1998-04-30
Completion date
2001-03-31
Last updated
2009-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia, Schizophrenic Disorder

Brief summary

The goal of this research program is to implement a series of psychoeducational training classes designed to teach individuals with schizophrenia the importance of medication treatment, how to identify and manage medication side effects, and how to make appointments and emergency plans. The skills taught to the research subjects will lead to demonstrable increases (compared to the control group) in adherence to both the prescribed medication regimen and scheduled outpatient appointments and thereby cause a decrease (again compared to the control group) in rehospitalization rates and bed-days during subsequent twelve months following the intervention. A secondary objective of this work is that if the CREP program is successful and/or illness education is effective, the data will be able to disseminated throughout the VISN 22 via the recently awarded Mental Illness Research Education and Clinical Center (MIRECC) program.

Interventions

BEHAVIORALCommunity Re-Entry Program: What is Schizophrenia

Sponsors

US Department of Veterans Affairs
Lead SponsorFED

Study design

Intervention model
PARALLEL

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. Age 18-65 years of age. 2. DSM IV diagnosis of schizophrenia or schizoaffective disorder. 3. Competent to give informed consent. 4. Previously participated in Brief Hospitalization for Schizophrenia: Strategies to Improve Treatment Outcome Principal Investigator. Donna Wirshing, M.D.

Exclusion criteria

1. Physical or cognitive impairment of such severity as to adversely affect the validity of clinical ratings or impair capacity to give informed consent. 2. History of substantial substance dependence 6 months prior to the study. 3. Patients at high risk of suicide or other directed violence.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026